Literature DB >> 25973296

Role of miR-100 in the radioresistance of colorectal cancer cells.

Xiao-Dong Yang1, Xiao-Hui Xu2, Shu-Yu Zhang3, Yong Wu1, Chun-Gen Xing1, Gan Ru1, Hong-Tao Xu1, Jian-Ping Cao3.   

Abstract

The prognosis of radioresistant colorectal cancer (CRC) is generally poor. Abnormal expression of microRNAs (miRNAs) is involved in the radiosensitivity of various tumor cells as these RNAs regulate biological signaling pathways. However, radioresistance-associated miRNAs in CRC have not yet been identified. In this study, we filtered out HCT116 and CCL-244 from seven CRC cell lines that showed the highest difference in radiosensitivity in a clonogenic assay. MiRNA sequencing identified 33 differentially expressed miRNAs (13 up-regulated and 20 down-regulated) in CCL-244 and 37 in HCT116 (20 up-regulated and 17 down-regulated) cells. MiR-100 was significantly down-regulated in CCL-244 cells after X-ray irradiation but not in HCT116 cells. Quantitative real-time PCR showed that the expression of miR-100 in CRC tissues was significantly lower than that in normal tissues. Thus, miR-100 seems to be involved in the radioresistance of CCL-244 cells. MiR-100 up-regulation sensitized CCL-244 cells to X-ray irradiation, which probably led to apoptosis and DNA double-strand breaks in these. In conclusion, to our knowledge, this is the first study to show that miR-100 may play an important role in regulating the radiosensitivity of CRC, and it may act as a new clinical target for CRC radiotherapy.

Entities:  

Keywords:  Colorectal cancer; miR-100; miRNA profiling; radioresistance; radiosensitivity

Year:  2015        PMID: 25973296      PMCID: PMC4396051     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  48 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  MicroRNAs are significantly influenced by p53 and radiation in HCT116 human colon carcinoma cells.

Authors:  Sangsu Shin; Hwa Jun Cha; Eun-Mee Lee; Jin Hyuk Jung; Su-Jae Lee; In-Chul Park; Young-Woo Jin; Sungkwan An
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

3.  NCCN Clinical Practice Guidelines in Oncology: rectal cancer.

Authors:  Paul F Engstrom; Juan Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Anne Covey; Raza A Dilawari; Dayna S Early; Peter C Enzinger; Marwan G Fakih; James Fleshman; Charles Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Edward Lin; Mary F Mulcahy; Sujata Rao; David P Ryan; Leonard Saltz; David Shibata; John M Skibber; Constantinos Sofocleous; James Thomas; Alan P Venook; Christopher Willett
Journal:  J Natl Compr Canc Netw       Date:  2009-09       Impact factor: 11.908

4.  Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J.

Authors:  Wooi Loon Ng; Dan Yan; Xiangming Zhang; Yin-Yuan Mo; Ya Wang
Journal:  DNA Repair (Amst)       Date:  2010-11-10

5.  Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan.

Authors:  V Boni; R Zarate; J C Villa; E Bandrés; M A Gomez; E Maiello; J Garcia-Foncillas; E Aranda
Journal:  Pharmacogenomics J       Date:  2010-06-29       Impact factor: 3.550

6.  Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols.

Authors:  N Mirkovic; D W Voehringer; M D Story; D J McConkey; T J McDonnell; R E Meyn
Journal:  Oncogene       Date:  1997-09-18       Impact factor: 9.867

Review 7.  Apoptosis in cancer--implications for therapy.

Authors:  Henning Schulze-Bergkamen; Peter H Krammer
Journal:  Semin Oncol       Date:  2004-02       Impact factor: 4.929

8.  MicroRNA-100 regulates IGF1-receptor expression in metastatic pancreatic cancer cells.

Authors:  J S Huang; M E Egger; W E Grizzle; L R McNally
Journal:  Biotech Histochem       Date:  2013-02-04       Impact factor: 1.718

9.  miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling.

Authors:  C A Gebeshuber; J Martinez
Journal:  Oncogene       Date:  2012-08-27       Impact factor: 9.867

10.  Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma.

Authors:  Shi-Yun Cui; Jia-Yuan Huang; Yi-Tian Chen; Hai-Zhu Song; Bing Feng; Gui-Chun Huang; Rui Wang; Long-Bang Chen; Wei De
Journal:  Mol Cancer Res       Date:  2013-04-05       Impact factor: 5.852

View more
  21 in total

1.  Involvement of miR-155/FOXO3a and miR-222/PTEN in acquired radioresistance of colorectal cancer cell line.

Authors:  Hamed Manoochehri Khoshinani; Saeid Afshar; Abdolazim Sedighi Pashaki; Ali Mahdavinezhad; Safora Nikzad; Rezvan Najafi; Razieh Amini; Mohammad Hadi Gholami; Alireza Khoshghadam; Massoud Saidijam
Journal:  Jpn J Radiol       Date:  2017-09-06       Impact factor: 2.374

2.  MiR-218 and miR-100 polymorphisms as markers of irinotecan-based chemotherapy response in metastatic colorectal cancer.

Authors:  Dimitra-Ioanna Lampropoulou; Gerasimos Aravantinos; Konstantinos Laschos; Theodosis Theodosopoulos; Christos Papadimitriou; Maria Gazouli
Journal:  Int J Colorectal Dis       Date:  2019-10-09       Impact factor: 2.571

3.  Differential expression of microRNA between triple negative breast cancer patients of African American and European American descent.

Authors:  William M MacCuaig; Alexandra Thomas; Juan C Claros-Sorto; Jorge G Gomez-Gutierrez; Adam C Alexander; Elizabeth A Wellberg; William E Grizzle; Lacey R McNally
Journal:  Biotech Histochem       Date:  2022-01-04       Impact factor: 1.834

4.  IFI35 is involved in the regulation of the radiosensitivity of colorectal cancer cells.

Authors:  Yan Hu; Bing Wang; Ke Yi; Qingjun Lei; Guanghui Wang; Xiaohui Xu
Journal:  Cancer Cell Int       Date:  2021-06-03       Impact factor: 5.722

5.  Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells.

Authors:  Yiting Tang; Yayun Cui; Zengpeng Li; Zhuqing Jiao; Yong Zhang; Yan He; Guangxia Chen; Guangxia Cheng; Qunyan Zhou; Wenjie Wang; Xifa Zhou; Judong Luo; Shuyu Zhang
Journal:  J Exp Clin Cancer Res       Date:  2016-01-12

Review 6.  MicroRNAs Involvement in Radioresistance of Head and Neck Cancer.

Authors:  Parwez Ahmad; Jiri Sana; Marek Slavik; Pavel Slampa; Pavel Smilek; Ondrej Slaby
Journal:  Dis Markers       Date:  2017-02-23       Impact factor: 3.434

7.  miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1.

Authors:  Li Zheng; Jiangtao Chen; Zhongyong Zhou; Zhikuan He
Journal:  Onco Targets Ther       Date:  2017-02-20       Impact factor: 4.147

Review 8.  MicroRNAs: Clinical Relevance in Colorectal Cancer.

Authors:  Joe Thomas; Masahisa Ohtsuka; Martin Pichler; Hui Ling
Journal:  Int J Mol Sci       Date:  2015-11-25       Impact factor: 5.923

9.  Roles of microRNA-99 family in human glioma.

Authors:  Mingyu Zhang; Yong Guo; Jun Wu; Fenghua Chen; Zhijie Dai; Shuangshi Fan; Pengcheng Li; Tao Song
Journal:  Onco Targets Ther       Date:  2016-06-20       Impact factor: 4.147

10.  Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.

Authors:  Jing Yu; Ning Li; Xin Wang; Hua Ren; Weihu Wang; Shulian Wang; Yongwen Song; Yueping Liu; Yexiong Li; Xuantong Zhou; Aiping Luo; Zhihua Liu; Jing Jin
Journal:  Oncotarget       Date:  2016-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.